R eplication and release of hepatitis B virus (HBV) from hepatocytes lead to a decrease of the adaptive immune response, and a enhancement of the non-specific immune response, which allows HBV to withstand the host specific immune response and leads to chronic infection. At the same time, the non-specific immune response enhances the inflammation of liver. However, the mechanism of immune tolerance to hepatitis B virus, and molecular mechanism of inflammation of the liver damage caused by HBV is still not clear. In previous studies, we transfected HepG2 cells with hepatitis B virus large surface protein (LHB), and made a gene microarray analysis. The result showed that a number of genes expression changed, including novel gene C12orf49. 1 LHB has a dual transmembrane topology, 2 with direct hepatocyte toxicity and carcinogenicity, transactivation, enhanced virus replication and the up-regulation of HBV covalently closed circular DNA (HBV cccDNA) copies.
R eplication and release of hepatitis B virus (HBV) from hepatocytes lead to a decrease of the adaptive immune response, and a enhancement of the non-specific immune response, which allows HBV to withstand the host specific immune response and leads to chronic infection. At the same time, the non-specific immune response enhances the inflammation of liver. However, the mechanism of immune tolerance to hepatitis B virus, and molecular mechanism of inflammation of the liver damage caused by HBV is still not clear. In previous studies, we transfected HepG2 cells with hepatitis B virus large surface protein (LHB), and made a gene microarray analysis. The result showed that a number of genes expression changed, including novel gene C12orf49. 1 LHB has a dual transmembrane topology, 2 with direct hepatocyte toxicity and carcinogenicity, transactivation, enhanced virus replication and the up-regulation of HBV covalently closed circular DNA (HBV cccDNA) copies. [3] [4] [5] [6] Furthermore, accumulation of LHB in the 
Gene cloning
Escherichia coli strains DH5α and Rosetta were used for cloning and expression of the recombinant C12orf49 protein, respectively. The E. coli cells harbouring recombinant plasmids were grown aerobically at 37 ℃ in Luria-Bertani broth with 100 μg/ml ampicillin. Plasmid pET-32a was used as an expression vector. According to the coding region of the C12orf49 sequence, a pair of oligonucleotide primers (forward primer: 5'-GGTACCACCTTCAAG-C A G G A G G A G A G G G C -3 ' , r e v e r s e p r i m e r : 5'-CTCGAGAGCGGGGAAGAGCTCGGG-3') was designed and synthesized, incorporated with KpnⅠ and XhoⅠrestriction enzyme site, respectively. Then C12orf49 was amplified with PCR technology using HepG2 cDNA as the template. The reaction conditions was 95 ℃ for 5 minutes; 95 ℃ for 30 seconds, 58 ℃ for 30 seconds and 72 ℃ for 1 minute, 35 cycles total; 72 ℃ for 10 minutes; 4 ℃ placed. The amplification products was identified and purified by 1% agarose gel. The purified C12orf49 fragment was ligated into pGEM-T vector. pGEM-T-C12orf49 plasmid was digested with restriction enzymes KpnⅠ and XhoⅠ, and identified by sequencing. Correct C12orf49 fragment was digested from pGEM-T-C12orf49 and ligated into the KpnⅠ-XhoⅠ sites of pET32a vector, which provides six his residues at the N-terminus of the expressed protein. Recombinant vector pET32a-C12orf49 was transformed into competent E. coli DH5α and identified by enzyme digestion and sequencing.
Expression of recombinant C12orf49 protein
For expression of the recombinant protein, correct recombinant vector pET32a-C12orf49 plasmid was transformed into competent E. coli Rosetta. E. coli Rosetta harbouring pET32a-C12orf49 vector were grown in LB medium supplemented with ampicillin (100 μg/ml) at 37 ℃ with shaking (250 rpm) until the absorbance reached approximately 0.6~0.8. Then, isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final concentration of 1 mmol/L. The cells were incubated for a further 6 hours before being harvested. Pellet of BL-21 cells harbouring C12orf49 was repeatedly frozen and thawed, and then be suspended by gentle stirring in buffer (20 mmol/L Tris-HCl, 5 mmol/L EDTA, pH 8.0). The suspension was subjected to ultrasonication (Pulse on 5 s, pulse off 5 s, for 5 min; pulse on 20 s, pulse off 20 s, until A value never decreased any more).
1 After centrifugation, the supernatant was denoted as A, and the precipitate was washed by wash buffer (8 mol/L urea, 20 mmol/ L Tris-HCI, 5 mmol/L EDTA, 100 mmol/L NaCl, 1% Triton X-100) and ddH 2 O, supernatants were denoted as B and C. Then precipitate was soluted by solution buffer (10 mmol/L imidazole, 8 mol/L urea) . Then A, B, C and D were examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) to verify the expression of recombinant C12orf49 protein. Supernatants D was slowly dialysis at 4 ℃ to remove the high concentrations of urea and make protein refolding. PEG20 000 was used to concentrate the protein, and BCA method was use to determine the protein concentration. Western blot was used to identify the recombinant protein. 
Preparation of rabbit anti-C12orf49 protein
Male rabbits were immunized with recombinant C12orf49 protein in the 1 st, 3 rd, and 4 th week. Protein was injected in subcutaneous of neck, back or groin of the rabbits, and the dose of C12orf49 protein was 1 mg (the first week, with equal volume of Freund's complete adjuvant emulsion), 0.5 mg ( the second week), and 0.5 mg (the third week). Blood was collected from ear vein of rabbits at 0 week, 1 week, 3 week, and 4 week, and the serum were preserved to test the titer of antibody with ELISA. In the fifth week, on the third day after immunization, we collected all serum of the rabbits, and preserved it at -80 ℃. Purification of polyclonal antibody and specificity was detected by affinity chromatography using protein A and SDS-PAGE electrophoresis, respectively.
Effects of C12orf49 recombinant protein on proliferation of HepG2 cell
HepG2 cells were collected at logarithmic phase, replated in the plate with 2 000 cells per well and incubated at 2.5% CO 2 , 37 ℃ for 12 h. The cells were directly stimulated by C12orf49 recombinant protein at the concentration of 0, 1, 10, 20, 50 and 100 ng/ml, and cultured for a further 48 hours. And then each well was added with 10 μL 0.5% MTT solution, supernatant was discarded after another 4 more hours, and each well was added with 150 μl dimethyl sulfoxide (DMSO) to solute the formazan. According to the A value (60 repeats each) reading at 570 nm of each well, the effect of C12orf49 on proliferation of HepG2 cell was analyzed.
Statistical methods
Mean differences was tested with One Way ANOVA analysis using SPSS13.0 statistical software. P < 0.05 was considered significant.
RESULTS
Specific primers were designed to amplify C12orf49 gene, and C12orf49 gene fragment was successfully amplified from the HepG2 cDNA template ( Figure  1 ). The C12orf49 gene fragment was cloned into pET32a(+) vector. By the identification of double digestion of pET32a-C12orf49 using KpnⅠ and XhoⅠ restriction enzymes (Figure 2 ) and gene sequencing, we successfully constructed the prokaryotic expression plasmid of C12orf49. Cloned C12orf49 gene sequence showed 100% homology with the reference sequences. E. coli BL-21(DE3) cells harbouring pET32a-C12orf49 plasmid were cultured at 37 ℃ in the presence and absence of IPTG. Induction of the cells with IPTG (1 mmol/L) at 37 ℃ for 6 h was found to be optimal to achieve high-level expression of C12or49, and it had been identified by Western blot that it was recombinant protein induced by IPTG (Figure 3) . A, B, C and D supernatant were tested for the presence of recombinant proteins, and the majority of the expressed protein was detected in D supernatant with higher concentration and purity (Figure 3) . To further characterize the functions of C12orf49 gene, we prepared the rabbit anti-C12orf49 antibody. The titer of the antibody could reach 1:1 280 000 (Table1), and purified C12orf49 antibody had a good concentration and a high specificity (Figure 4) .
MTT method was used to observe the effects of C12orf49 protein on the proliferation of HepG2 cell ( Figure 5 ). Compared with control (0 ng/ml group), 1 ng/ml group and 10 ng/ml group had a significant difference with it.
DISCUSSION
After HBV infection, the host immune system can start The process of HBV infects host and causes liver cells injury contains a complex mechanism. It needs the participation of innate and HBV specific adaptive immune system. 6, 7 Animal model studies also indicated that antigen-specific cells, activation antigen nonspecific cells and effector molecules in liver were all involved in the process of viral hepatitis. So apoptosis, autophagy, and endoplasmic reticulum stress concepts have become the new theories of liver cell injury. [8] [9] [10] [11] In this study, MTT method was used to observe the effects of C12orf49 protein on the proliferation of HepG2 cell ( Figure 5 ). According to the present results, low level recombinant C12orf49 protein stimulation made a significant effect (MTT experiment) on the proliferation of HepG2 cells. It suggested that C12orf49 protein might have an advanced effect on HepG2 cells at a suitable concentration. The effect of the gene on hepatic parenchymal and stromal cell and its role in the process of HBV replication was still uncertain. C12orf49 as a new gene whose function is still unknown, may be related to the multi-links after HBV infection process and its functional studies are still in progress.
